{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:18:26Z","timestamp":1692703106536},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.6774","type":"journal-article","created":{"date-parts":[[2012,10,14]],"date-time":"2012-10-14T23:22:42Z","timestamp":1350256962000},"page":"2869-2875","source":"Crossref","is-referenced-by-count":7,"title":["Risk Factors for &lt;i&gt;Pneumocystis jiroveci&lt;\/i&gt; Pneumonia in Glomerulonephritis Patients Receiving Immunosuppressants"],"prefix":"10.2169","volume":"51","author":[{"given":"Chih-Yu","family":"Yang","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taiwan"},{"name":"School of Medicine, National Yang-Ming University, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Hang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Taipei Veterans General Hospital, Taiwan"},{"name":"School of Medicine, National Yang-Ming University, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu-Chang","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taiwan"},{"name":"School of Medicine, National Yang-Ming University, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ching","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taiwan"},{"name":"School of Medicine, National Yang-Ming University, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lertnawapan R, Totemchokchyakarn K, Nantiruj K, Janwityanujit S. Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus. Rheumatol Int 29: 491-496, 2009.","DOI":"10.1007\/s00296-008-0721-6"},{"key":"2","unstructured":"2. Ognibene FP, Shelhamer JH, Hoffman GS, et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 151 (3 Pt 1): 795-799, 1995."},{"key":"3","unstructured":"3. Jarrousse B, Guillevin L, Bindi P, et al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 11: 615-621, 1993."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Carmona EM, Limper AH. Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis 5: 41-59, 2011.","DOI":"10.1177\/1753465810380102"},{"key":"5","unstructured":"5. Kadoya A, Okada J, Iikuni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus. J Rheumatol 23: 1186-1188, 1996."},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M"},{"key":"7","unstructured":"7. De CN, Xu F, Porcher R, Pavie J, Molina JM, Peraldi MN. Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case-control study. Clin Microbiol Infect 16: 1375-1377, 2010."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Eitner F, Hauser IA, Rettkowski O, et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant 26: 2013-2017, 2011.","DOI":"10.1093\/ndt\/gfq689"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Struijk GH, Gijsen AF, Yong SL, et al. Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation. Nephrol Dial Transplant 26: 3391-3398, 2011.","DOI":"10.1093\/ndt\/gfr048"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 197: 10-17, 2008.","DOI":"10.1086\/523814"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Schiff J, Cole E, Cantarovich M. Therapeutic monitoring of calcineurin inhibitors for the nephrologist. Clin J Am Soc Nephrol 2: 374-384, 2007.","DOI":"10.2215\/CJN.03791106"},{"key":"12","unstructured":"13. Scholl U, Wastl U, Risler T, et al. The \"point of no return\" and the rate of progression in the natural history of IgA nephritis. Clin Nephrol 52: 285-292, 1999."},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Pozzi C, Del VL, Locatelli F. Can immunosuppressive therapy be useful in IgA nephropathy when the 'Point of No Return' has already been exceeded? Nephron 92: 699-701, 2002.","DOI":"10.1159\/000064080"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.129"},{"key":"15","unstructured":"17. Scamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure. Semin Nephrol 16: 183-191, 1996."},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-199311000-00005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"20. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78: S206-S211, 2001.","DOI":"10.1046\/j.1523-1755.2001.07804.x"},{"key":"18","unstructured":"21. Boonsarngsuk V, Sirilak S, Kiatboonsri S. Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int J Infect Dis 13: 59-66, 2009."},{"key":"19","doi-asserted-by":"crossref","unstructured":"23. Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 131: 1173-1180, 2007.","DOI":"10.1378\/chest.06-1467"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1680"},{"key":"21","doi-asserted-by":"crossref","unstructured":"27. Matsumura Y, Shindo Y, Iinuma Y, et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis 11: 76, 2011.","DOI":"10.1186\/1471-2334-11-76"},{"key":"22","doi-asserted-by":"crossref","unstructured":"28. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 15 34: 1098-1107, 2002.","DOI":"10.1086\/339548"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.4065\/82.9.1052"},{"key":"24","doi-asserted-by":"crossref","unstructured":"30. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant 17 Suppl 4: 36-39, 2002.","DOI":"10.1093\/ndt\/17.suppl_4.36-a"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/20\/51_51.6774\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:42:50Z","timestamp":1621446170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/20\/51_51.6774\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":24,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.6774","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}